Skip to content

A prospective comparison of Etiology and outcomes of Patients with Community-Acquired or Health Care-Associated Pneumonia

A prospective comparison of Etiology and outcomes of Patients with Community-Acquired or Health Care-Associated Pneumonia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1090220054
Enrollment
750
Registered
2011-01-27
Start date
2009-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Community-Acquired or Health Care-Associated

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Sponsors

Mie University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with pneumonia Pneumonia is diagnosed on the basis of presence of clinical symptoms, laboratory finding and a new infiltrate on chest radiography.

Exclusion criteria

Exclusion criteria: Patients with acute congestive heart failure, pulmonary infarction, interstitial pneumonia or lung cancer-associated obstructive pneumonia.

Design outcomes

Primary

MeasureTime frame
1) To evaluate etiology and outcome of HCAP using the new argolism. 2) To compare etiology and outcome of HCAP with CAP

Countries

Japan

Contacts

Public ContactTakaya Maruyama

National Hospital Organization Mie National Hospital

takaya51116@y7.dion.ne.jp+81-59-232-2531

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026